Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 62

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 5
Chunk 62
---
  

Avenanthramides

During the year ended December 31, 2012, Ceapro entered
into a licence agreement with the Canadian Government for a new technology to increase the concentration of avenanthramides in oats
(the “ Avenanthramides Agreement”). This unique technology represents a way to manage the risks related the availability and
quality of raw material used in production and provides for the ability to produce higher concentrations of avenanthramides which should
enable the production of larger quantities of product allowing Ceapro to grow its cosmeceutical sector while also allowing for the development
of pharmaceutical-grade powder formulations as part of Ceapro’s transition to nutraceuticals and pharmaceuticals. The Avenanthramides
Agreement remains in force until the last patent has expired which will be in March of 2030, or until the patents have been abandoned.

  Organizational structure  
 ────────────────────────────

Our corporate structure, the jurisdiction of incorporation
of our direct and indirect subsidiaries and the percentage of shares that we held in those subsidiaries as at December 31, 2024 is depicted
in the chart set forth under the caption “ Item 4. A. History and development of the Company”.

  Property and equipment  
 ──────────────────────────

Our registered address is located in Toronto, Canada.
Our largest office is located in Edmonton Alberta, and we have an additional offices in Frankfurt, Germany and Summerville, South Carolina.
We do not own any real property. Effective November, 2024, the Company and its landlord mutually agreed to a five-year extension to its
existing building lease agreements for its Ceapro subsidiary.

The following table sets forth information with respect
to our main facilities as at December 31, 2024.

  Location                                   Use of space                                                                               Square Footage      Type of interest  
  315 Sigma Drive, Summerville SC 29486      Occupied for administration                                                                           168      Leasehold         
  Weismüllerstr. 50                          Occupied for management, R& D, business development and administration                              7,319      Leasehold         
                                                                                                                                                                              
  D-60314                                                                                                                                                                     
                                                                                                                                                                              
  Frankfurt-am-Main, Germany                                                                                                                                                  
  7824 51 Ave NW, Edmonton, AB T6E 6W2       Occupied for management, manufacturing, R& D, business development and administration              29,764      Leasehold         
  8339 Roper Rd